000

HUNAN HANSEN PHARM

No trades
See on Supercharts
Market capitalization
‪2.60 B‬CNY
‪167.62 M‬CNY
‪898.09 M‬CNY
‪295.49 M‬
Beta (1Y)
1.25

About HUNAN HANSEN PHARM

CEO
Zheng Qing Liu
Headquarters
Yiyang
Employees (FY)
‪1.53 K‬
Founded
1998
ISIN
CNE100000PK2
FIGI
BBG000Q7Z266
Hunan Hansen Pharmaceutical Co. Ltd. engages in the research, development, production, manufacture, and sales of traditional Chinese medicines. Its products include intravenous medicine, capsules, syrups, and pills for cardiovascular, respiratory, orthopedic diseases, cerebrovascular diseases, and gastrointestinal diseases. The company was founded on January 21, 1998 and is headquartered in Hunan, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 002412 is 5.09 CNY — it has decreased by 1.55% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HUNAN HANSEN PHARM stocks are traded under the ticker 002412.
HUNAN HANSEN PHARM is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
002412 stock is 1.97% volatile and has beta coefficient of 1.25. Check out the list of the most volatile stocks — is HUNAN HANSEN PHARM there?
Yes, you can track HUNAN HANSEN PHARM financials in yearly and quarterly reports right on TradingView.
002412 stock has fallen by 7.96% compared to the previous week, the month change is a 8.45% fall, over the last year HUNAN HANSEN PHARM has showed a 22.64% decrease.
002412 net income for the last quarter is ‪19.08 M‬ CNY, while the quarter before that showed ‪35.60 M‬ CNY of net income which accounts for −46.42% change. Track more HUNAN HANSEN PHARM financial stats to get the full picture.
Today HUNAN HANSEN PHARM has the market capitalization of ‪2.60 B‬, it has decreased by 3.14% over the last week.
Yes, 002412 dividends are paid annually. The last dividend per share was 0.30 CNY. As of today, Dividend Yield (TTM)% is 5.80%. Tracking HUNAN HANSEN PHARM dividends might help you take more informed decisions.
HUNAN HANSEN PHARM dividend yield was 4.89% in 2022, and payout ratio reached 90.06%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 002412 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUNAN HANSEN PHARM stock right from TradingView charts — choose your broker and connect to your account.
002412 reached its all-time high on Jun 15, 2015 with the price of 23.82 CNY, and its all-time low was 4.08 CNY and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪1.53 K‬ employees. See our rating of the largest employees — is HUNAN HANSEN PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUNAN HANSEN PHARM technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUNAN HANSEN PHARM stock shows the sell signal. See more of HUNAN HANSEN PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.